author        = "Beltrán Palacios, Laura and Monzón Garcés, Marta and
                       Badiola Díez, Juan José",
      title         = "{Valoración de la cobertura vacunal antirrábica}",
      year          = "2016",
      note          = "Rabies is a viral infectious disease caused by
                       Lyssaviruses. It is a zoonotic disease characterized by
                       encephalomyelitis that leads affected animals to death in
                       most cases presenting clinical signs. Its distribution is
                       global, and despite the actual incidence in human species
                       is yet unknown, WHO estimates that 55,000 deaths occur each
                       year, mainly in developing countries. Spain is free of
                       terrestrial rabies since 1978. However, several imported
                       dog rabies (from Morocco) and nearly 20 bat rabies cases
                       have been diagnosed since that date. Taking into account
                       these epidemiological data and the geographical location
                       between Europe and endemic countries, it results necessary
                       to maximize control and prevention measures. The aim of
                       this study was to provide actual data concerning
                       vaccination coverage in 17 dogs from a shelter in Movera
                       (Zaragoza) by preliminary study about antibody titers
                       against rabies. An indirect-ELISA established by OIE was
                       applied on all sera in order to determine the rate of
                       seroconversion in animals analyzed. Out of the 17 samples
                       tested,23.5 % and 5.9 % presented antibody titers equal or
                       higher than 0.5UI/ml, respectively. These results indicate
                       an acceptable level of protection according to the OIE. The
                       remaining samples,70.6 % did not show titles with
                       protection levels (they were lower than 0.5 IU/ ml).",